Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127256) titled 'A study on the association between the adverse immune-inflammatory trajectory characterized by persistent lymphopenia combined with early C-reactive protein load and the 90-day mortality risk of elderly critically ill patients with active tumors' on June 28.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Zhejiang Provincial People's Hospital
Condition:
None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-30
Target Sample Size: Observation group:650;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?p...